Cargando…

Use of Electrospun Phenylalanine/Poly-ε-Caprolactone Chiral Hybrid Scaffolds to Promote Endothelial Remodeling

The fabrication of tissue-engineered vascular grafts to replace damaged vessels is a promising therapy for cardiovascular diseases. Endothelial remodeling in the lumen of TEVGs is critical for successful revascularization. However, the construction of well-functioning TEVGs remains a fundamental cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Benlin, Hou, Lei, Sun, Binbin, Han, Yu, Zou, Yunqing, Huang, Juexin, Zhang, Yanan, Feng, Chuanliang, Dou, Xiaoqiu, Xu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656108/
https://www.ncbi.nlm.nih.gov/pubmed/34900965
http://dx.doi.org/10.3389/fbioe.2021.773635
_version_ 1784612214588571648
author Sun, Benlin
Hou, Lei
Sun, Binbin
Han, Yu
Zou, Yunqing
Huang, Juexin
Zhang, Yanan
Feng, Chuanliang
Dou, Xiaoqiu
Xu, Feng
author_facet Sun, Benlin
Hou, Lei
Sun, Binbin
Han, Yu
Zou, Yunqing
Huang, Juexin
Zhang, Yanan
Feng, Chuanliang
Dou, Xiaoqiu
Xu, Feng
author_sort Sun, Benlin
collection PubMed
description The fabrication of tissue-engineered vascular grafts to replace damaged vessels is a promising therapy for cardiovascular diseases. Endothelial remodeling in the lumen of TEVGs is critical for successful revascularization. However, the construction of well-functioning TEVGs remains a fundamental challenge. Herein, chiral hybrid scaffolds were prepared by electrospinning using D/L-phenylalanine based gelators [D(L)PHEG] and poly-ε-caprolactone (PCL). The chirality of scaffolds significantly affected the endothelial remodeling progress of TEVGs. Compared with L-phenylalanine based gelators/poly-ε-caprolactone (L/PCL) and PCL, D-phenylalanine based gelators/poly-ε-caprolactone (D/PCL) scaffolds enhanced cell adhesion, and proliferation and upregulated the expression of fibronectin-1, and vinculin. These results suggests that chiral hybrid scaffolds can promote endothelial remodeling of TEVGs by upregulating adhesion-associated protein levels. This study offers an innovative strategy for endothelial remodeling of TEVGs by fabricating chiral hybrid scaffolds, and provides new insight for the treatment of cardiovascular diseases.
format Online
Article
Text
id pubmed-8656108
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86561082021-12-10 Use of Electrospun Phenylalanine/Poly-ε-Caprolactone Chiral Hybrid Scaffolds to Promote Endothelial Remodeling Sun, Benlin Hou, Lei Sun, Binbin Han, Yu Zou, Yunqing Huang, Juexin Zhang, Yanan Feng, Chuanliang Dou, Xiaoqiu Xu, Feng Front Bioeng Biotechnol Bioengineering and Biotechnology The fabrication of tissue-engineered vascular grafts to replace damaged vessels is a promising therapy for cardiovascular diseases. Endothelial remodeling in the lumen of TEVGs is critical for successful revascularization. However, the construction of well-functioning TEVGs remains a fundamental challenge. Herein, chiral hybrid scaffolds were prepared by electrospinning using D/L-phenylalanine based gelators [D(L)PHEG] and poly-ε-caprolactone (PCL). The chirality of scaffolds significantly affected the endothelial remodeling progress of TEVGs. Compared with L-phenylalanine based gelators/poly-ε-caprolactone (L/PCL) and PCL, D-phenylalanine based gelators/poly-ε-caprolactone (D/PCL) scaffolds enhanced cell adhesion, and proliferation and upregulated the expression of fibronectin-1, and vinculin. These results suggests that chiral hybrid scaffolds can promote endothelial remodeling of TEVGs by upregulating adhesion-associated protein levels. This study offers an innovative strategy for endothelial remodeling of TEVGs by fabricating chiral hybrid scaffolds, and provides new insight for the treatment of cardiovascular diseases. Frontiers Media S.A. 2021-11-25 /pmc/articles/PMC8656108/ /pubmed/34900965 http://dx.doi.org/10.3389/fbioe.2021.773635 Text en Copyright © 2021 Sun, Hou, Sun, Han, Zou, Huang, Zhang, Feng, Dou and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Sun, Benlin
Hou, Lei
Sun, Binbin
Han, Yu
Zou, Yunqing
Huang, Juexin
Zhang, Yanan
Feng, Chuanliang
Dou, Xiaoqiu
Xu, Feng
Use of Electrospun Phenylalanine/Poly-ε-Caprolactone Chiral Hybrid Scaffolds to Promote Endothelial Remodeling
title Use of Electrospun Phenylalanine/Poly-ε-Caprolactone Chiral Hybrid Scaffolds to Promote Endothelial Remodeling
title_full Use of Electrospun Phenylalanine/Poly-ε-Caprolactone Chiral Hybrid Scaffolds to Promote Endothelial Remodeling
title_fullStr Use of Electrospun Phenylalanine/Poly-ε-Caprolactone Chiral Hybrid Scaffolds to Promote Endothelial Remodeling
title_full_unstemmed Use of Electrospun Phenylalanine/Poly-ε-Caprolactone Chiral Hybrid Scaffolds to Promote Endothelial Remodeling
title_short Use of Electrospun Phenylalanine/Poly-ε-Caprolactone Chiral Hybrid Scaffolds to Promote Endothelial Remodeling
title_sort use of electrospun phenylalanine/poly-ε-caprolactone chiral hybrid scaffolds to promote endothelial remodeling
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656108/
https://www.ncbi.nlm.nih.gov/pubmed/34900965
http://dx.doi.org/10.3389/fbioe.2021.773635
work_keys_str_mv AT sunbenlin useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling
AT houlei useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling
AT sunbinbin useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling
AT hanyu useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling
AT zouyunqing useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling
AT huangjuexin useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling
AT zhangyanan useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling
AT fengchuanliang useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling
AT douxiaoqiu useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling
AT xufeng useofelectrospunphenylalaninepolyecaprolactonechiralhybridscaffoldstopromoteendothelialremodeling